Log In Create an Account

HOME
Topics
Atrial Fibrillation ATTR-CM Diabetes Heart Failure Hyperlipidemia Hypertension Hypertrophic Cardiomyopathy
Inflammation Kidney Disease Lifestyle Obesity Thrombosis
Medical News
Atrial Fibrillation ATTR-CM Diabetes Heart Failure Hyperlipidemia Hypertension Hypertrophic Cardiomyopathy
Inflammation Kidney Disease Lifestyle Obesity Thrombosis
CME
Atrial Fibrillation Diabetes Heart Failure Hyperlipidemia
Hereditary angioedema Hypertrophic Cardiomyopathy Kidney Disease Obesity
Congress Coverage
AHA 2025 ESC Congress 2025 ERA 2025 ESC Heart Failure 2025 EAS 2025
AHA 2024 ESC Congress 2024 EAS 2024 ERA 2024 ESC Heart Failure 2024 ACC.24
Programs
Live Events
About Us

Home
Meeting Reports
Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl

Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl

Meeting report with presentation slides, videos and online CME of the EBAC-accredited symposium held at ESC Congress 2023, Amsterdam, The Netherlands.

email

0-0 of 0

Title

Privacy
Terms
Cookies

NEED HELP?Contact Us

NEED HELP? Contact Us

Share on ReachMD

Discussion
Player

LIVE ON REACHMD RADIOBack to live radio

Loading...

00:00

00:00

On Air
Playlists

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free

You are now leaving PACE-CME and going to a site run by another organization.

Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.

Cancel Continue